Moneycontrol PRO
Upcoming Event : Register for INTRAZON 3.0 India's Largest Retail Intraday Traders Online Conference

Asia shares gain despite Chinese COVID case numbers rising

MSCI's broadest index of Asia-Pacific shares outside Japan was up 0.3%, after U.S. stocks ended the previous session with gains. The index is up 12% so far this month.

November 23, 2022 / 07:43 AM IST

Asian share markets were mostly in positive territory on Wednesday despite rising COVID-19 cases in mainland China leaving investors uncertain over how much the fresh outbreaks could slow the reopening of the world's second-largest economy.

MSCI's broadest index of Asia-Pacific shares outside Japan was up 0.3%, after U.S. stocks ended the previous session with gains. The index is up 12% so far this month.

Australian shares were up 0.7%, with most gains coming from mining and resources giants as a result of higher oil prices. Japan's stock market was closed for a national holiday.

New Zealand's central bank raised interest rates by 75 basis points - its largest ever move - on Wednesday to a near 14-year high of 4.25% and flagged more hikes are on the way as it struggles to contain stubbornly high inflation.

Hong Kong's Hang Seng Index was up 0.6% in early trade while China's CSI300 Index opened broadly flat.

COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more
Show

China on Wednesday reported 29,157 new COVID infections for Nov. 22, according to the National Health Commission, compared with 28,127 new cases a day earlier. Case numbers in Beijing and Shanghai are steadily rising, prompting authorities to close some facilities.

"The biggest story for investors in Asia is still the China reopening," said Suresh Tantia, Credit Suisse's senior investment strategist in Singapore.

"We had seen China markets rally up to 20% but those expectations are being dialled back, we think a reopening will be a slower process and will not be done in a hurry. That means a lot of investors are trimming their exposure, cutting their losses or booking any profits they might have made on China."

Meanwhile the release of U.S. Federal Reserve minutes from its November policy meeting later on Wednesday is being keenly awaited by investors as they look for insight of how officials view economic conditions.

The Dow Jones Industrial Average rose 1.2% to 34,098.1 on Tuesday, the S&P 500 gained 1.4% to 4,003.58 and the Nasdaq Composite added 1.4% to 11,174.41. Energy stocks led the gains, stoked by rising oil prices.

The yield on benchmark 10-year Treasury notes rose to 3.7578% compared with its U.S. close of 3.758% on Tuesday.

Two-year yield, which rises with traders' expectations of higher Fed fund rates, touched 4.5227% compared with a U.S. close of 4.517%.

The dollar dropped 0.02% against the yen to 141.21.

The European single currency was up 0.0x?% on the day at $1.0303, having gained 4.26% in a month, while the dollar index, which tracks the greenback against a basket of currencies of other major trading partners, was down at 107.14.

"The U.S. dollar lost a little of its recent gains (as) central bankers' consensus about how much more interest rates should rise is fraying," Commonwealth Bank analyst Tobin Gorey wrote on Wednesday.

"Smaller or fewer rate rises are perhaps not a cause for optimism, it is cause for less pessimism."

Oil remained higher on Wednesday after top exporter Saudi Arabia said OPEC+ would maintain output cuts and could take further steps to balance the market.

In Asian trading, U.S. crude ticked up 0.3% to $81.15 a barrel. Brent crude rose to $88.35 per barrel.

Gold was slightly lower. Spot gold was traded at $1740.09 per ounce. [GOL/]

While the FTX exchange collapse continues to roil cryptocurrency markets, Bitcoin was 0.33% higher in Asian trading hours to $16,184.
Reuters
first published: Nov 23, 2022 07:43 am